Anti-RhoA + RhoC antibody [EPR18133]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal RHOA antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Mouse, Rat, Human samples. Cited in 5 publications.
View Alternative Names
ARH12, ARHA, RHO12, RHOA, Transforming protein RhoA, Rho cDNA clone 12, h12, ARH9, ARHC, RHOC, Rho-related GTP-binding protein RhoC, Rho cDNA clone 9, h9
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RhoA + RhoC antibody [EPR18133] (AB187026)
Immunohistochemical analysis of paraffin-embedded Human transitional cell carcinoma of bladder tissue labeling RhoA + RhoC with ab187026 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. Cytoplasmic staining on cancer cells of transitional cell carcinoma of bladder is observed. Counter stained with Hematoxylin.
Negative control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-RhoA + RhoC antibody [EPR18133] (AB187026)
Intracellular flow cytometric analysis of 2% paraformaldehyde-fixed Jurkat (Human T cell leukemia cells from peripheral blood) cells labeling RhoA + RhoC with ab187026 at 1/400 dilution (red) compared with a rabbit monoclonal IgG isotype control (ab172730; black) and a unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (FITC) at 1/150 dilution was used as the secondary antibody.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RhoA + RhoC antibody [EPR18133] (AB187026)
Immunohistochemical analysis of paraffin-embedded Mouse kidney tissue labeling RhoA + RhoC with ab187026 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. Cytoplasmic staining on kidney tubules of mouse kidney is observed. Counter stained with Hematoxylin.
Negative control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RhoA + RhoC antibody [EPR18133] (AB187026)
Immunohistochemical analysis of paraffin-embedded Rat stomach tissue labeling RhoA + RhoC with ab187026 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. Cytoplasmic staining on epithelial cells of rat stomach is observed. Counter stained with Hematoxylin.
Negative control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-RhoA + RhoC antibody [EPR18133] (AB187026)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized NIH/3T3 (Mouse embyro fibroblast cells) cells labeling RhoA + RhoC with ab187026 at 1/500 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/500 dilution (green). Confocal image showing cytoplasmic staining on NIH 3T3 cells is observed. The nuclear counter stain is DAPI (blue). Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution (red).
The negative controls are as follows :
1. ab187026 at 1/500 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution.
2. ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/500 dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-RhoA + RhoC antibody [EPR18133] (AB187026)
Immunoprecipitation of RhoA + RhoC from 1mg of NIH/3T3 (Mouse embyro fibroblast cells) whole cell lysate achieved using ab187026 at 1/50 dilution.
Lane 1 : Input : 10μg of NIH/3T3 whole cell lysate.
Lane 2 : NIH/3T3 whole cell lysate following IP with ab187026.
Lane 3 : Negative control : IP using Rabbit monoclonal IgG (ab172730) instead of ab187026 in NIH/3T3 whole cell lysates.
Western blot was performed using ab187026 at 1/1000 dilution.
VeriBlot for IP Detection Reagent (HRP) (ab131366) at 1/1500 was used for detection.
Blocking and dilution buffer and concentration : 5% NFDM/TBST. 30 second exposure.
All lanes:
Immunoprecipitation - Anti-RhoA + RhoC antibody [EPR18133] (ab187026)
false
- WB
Supplier Data
Western blot - Anti-RhoA + RhoC antibody [EPR18133] (AB187026)
5% NFDM/TBST : Blocking and diluting buffer.
All lanes:
Western blot - Anti-RhoA + RhoC antibody [EPR18133] (ab187026) at 1/2000 dilution
Lane 1:
Human fetal brain lysate at 10 mg/mL
Lane 2:
Human fetal kidney lysate at 10 mg/mL
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 22 kDa
Observed band size: 22 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-RhoA + RhoC antibody [EPR18133] (AB187026)
5% NFDM/TBST : Blocking and diluting buffer.
All lanes:
Western blot - Anti-RhoA + RhoC antibody [EPR18133] (ab187026) at 1/2000 dilution
Lane 1:
HepG2 (Human liver hepatocellular carcinoma) whole cell lysate at 10 µg
Lane 2:
HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate at 10 µg
Lane 3:
Jurkat (Human T cell leukemia cells from peripheral blood) whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 22 kDa
Observed band size: 22 kDa
false
Exposure time: 1min
- WB
Supplier Data
Western blot - Anti-RhoA + RhoC antibody [EPR18133] (AB187026)
5% NFDM/TBST : Blocking and diluting buffer.
Exposure time : Lane 1 : 30 seconds; lane 2 and 3 : 3 minutes.
Human RhoA full length protein (ab101594) contains aa1-193 with His-Tag® at N-Terminus; Human RhoB full length protein (ab107139) contains aa1-193 with His-Tag® at N-Terminus; Human RhoC full length protein (ab98085) contains aa1-190 with His-Tag® at N-Terminus.
The affinity of ab187016 to RhoA is higher than to RhoC.
Lanes 1 - 2:
Western blot - Anti-RhoA + RhoC antibody [EPR18133] (ab187026) at 1/20000 dilution
Lane 3:
Western blot - Anti-RhoA + RhoC antibody [EPR18133] (ab187026) at 1/500 dilution
Lane 1:
Human RhoA full length protein at 0.01 µg
Lane 2:
Human RhoB full length protein at 0.01 µg
Lane 3:
Human RhoC full length protein at 0.01 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 22 kDa
Observed band size: 22 kDa,24 kDa
false
- WB
Supplier Data
Western blot - Anti-RhoA + RhoC antibody [EPR18133] (AB187026)
5% NFDM/TBST : Blocking and diluting buffer.
All lanes:
Western blot - Anti-RhoA + RhoC antibody [EPR18133] (ab187026) at 1/2000 dilution
Lane 1:
Mouse brain lysate at 10 µg
Lane 2:
Mouse kidney lysate at 10 µg
Lane 3:
Rat brain lysate at 10 µg
Lane 4:
Rat kidney lysate at 10 µg
Lane 5:
C6 (Rat glial tumor cells) whole cell lysate at 10 µg
Lane 6:
Raw264.7(Mouse macrophage cells transformed with Abelson murine leukemia virus ) whole cell lysate at 10 µg
Lane 7:
PC12 (Rat adrenal gland pheochromocytoma ) whole cell lysate at 10 µg
Lane 8:
NIH 3T3 (Mouse embyro fibroblast cells ) whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 22 kDa
Observed band size: 22 kDa
false
Exposure time: 10s
Related conjugates and formulations (1)
-
Anti-RhoA + RhoC antibody [EPR18133] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The proteins RhoA and RhoC are key regulators in cell signaling pathways that coordinate cytoskeletal dynamics. They are integral parts of the Rho protein complex which includes other small GTPases like Rac1 and Cdc42. Through these interactions RhoA and RhoC influence cell cycle progression apoptosis and cellular transformations required during development and tissue repair. Their ability to control actomyosin contractility makes them significant for focal adhesion assembly and disassembly affecting cell movement.
Pathways
The activities of RhoA and RhoC are involved in the Rho signaling pathway and the Wnt signaling pathway. These pathways play an important role in guiding cellular architecture and communication. The Rho signaling pathway includes interactions with proteins like ROCK1 and ROCK2 which help modulate smooth muscle contraction and cell trophism. Meanwhile the Wnt signaling pathway involves cross-talk with β-catenin and influences cellular proliferation and growth pointing to RhoA and RhoC’s involvement in these essential signal transduction processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Diabetes, metabolic syndrome and obesity : targets and therapy 17:4339-4354 PubMed39582785
2024
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 9:e20118 PubMed37809525
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular pain 17:1744806921996101 PubMed33632015
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 20:2754-2762 PubMed31322244
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular biochemistry 119:2535-2544 PubMed28941295
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com